Articles tagged with Omniscan

Tags > O > Omniscan

Articles Tagged With 'Omniscan'

GE and Muzzled Radiologist End UK Libel Case

by Jeff Gerth, ProPublica - February 18, 2010 2:29 pm EDT

GE Healthcare has settled its libel lawsuit against Henrik Thomsen, the Danish radiologist who had raised questions about the safety … more

GE Suit Hushes Scientist Critical of Omniscan

by Jeff Gerth, ProPublica, and Jon Ungoed-Thomas, The Sunday Times - December 19, 2009 4:00 pm EDT

A version of this story was published with The Sunday Times (UK).

LONDON -- Two years ago in a conference room in the Randolph hote … more

FDA Advised to Tighten Restrictions on GE and Covidien MRI Drugs

by Jeff Gerth, ProPublica - December 9, 2009 3:35 pm EDT

Feds May Tighten Rules on Omniscan, a GE MRI Drug

by Jeff Gerth, ProPublica - December 2, 2009 5:55 pm EDT

Dec. 2, 2009: This post has been corrected.

The U.S. Food and Drug Administration is weighing further regulation of three drugs use … more

FDA to Take a Second Look at Warnings on MRI Drugs

by Jeff Gerth, ProPublica - October 16, 2009 2:37 pm EDT

Federal regulators plan to meet in December to review a 2007 decision to issue a blanket warning about the risks of special imaging d … more

Specter of MRI Disease Haunts GE

by Jeff Gerth, ProPublica - October 15, 2009 4:16 pm EDT

In May 2006, medical regulators in Denmark issued a warning that signaled trouble for General Electric. Danish researchers noted tha … more

How Three University Medical Centers Handled GE’s Omniscan

by Jeff Gerth, ProPublica - October 15, 2009 4:14 pm EDT

In 2006, Danish medical authorities began receiving reports that patients with serious kidney problems who underwent a magnetic reson … more

ProPublica Report

Enter your e-mail address
to receive our top stories daily.

Breaking on the Web: Omniscan

More...


© Copyright 2010 Pro Publica Inc.

FREE REPRINTS

 Unless otherwise noted, you can republish our articles and graphics (but not our photographs) for free. You just have to credit us and link to us, and you can’t edit our material or sell it separately. (We're licensed under Creative Commons, which provides the legal details.)